4-Bromo-2,3,5,6-tetrafluorobenzotrifluoride, 97.0%, 25g

N1-Cyclopropyl-2-chloroacetamide, 95.0%, 100g

Pentaerythritol Tetrakis(2-bromoisobutyrate)>95.0%(GC)1g

N,N-Dimethyl-4-(pyrrolidin-2-yl)aniline, 95.0%, 1g

(S)-tetrahydropyridazine-1,2,3-tricarboxylic acid 1,2-di-tert-butyl ester, 98.0%, 25g

(1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid, 95.0%, 5g

2,2,2-Trichloroacetamide, 95.0%, 500g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)25g

benzyl 1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate, 97.0%, 500mg

Methyl 4-hydroxycinnamate, 95.0%, 1g

1-Benzyl 3-methyl 5-hydroxypiperidine-1,3-dicarboxylate, 95.0%, 250mg

(R)-2-Amino-3-(3-(trifluoromethoxy)phenyl)propanoic acid, 95%, 500mg

Compact scales EMB series, 0.1 g, 500 g, EMB 500-1